Recent Advances of Platinum-Based Anticancer Complexes in Combinational Multimodal Therapy

被引:37
|
作者
Zhong, Tianyuan [1 ,2 ]
Yu, Jie [1 ,2 ]
Pan, Yong [1 ,2 ]
Zhang, Ning [3 ]
Qi, Yanxin [1 ,2 ]
Huang, Yubin [1 ,2 ]
机构
[1] Northeast Normal Univ, Fac Chem, Changchun 130024, Peoples R China
[2] Northeast Normal Univ, Key Lab Sustainable Adv Funct Mat Jilin Prov, Changchun 130024, Peoples R China
[3] Harbin Med Univ, Dept Orthoped, Affiliated Hosp 2, Harbin 150000, Peoples R China
基金
中国国家自然科学基金;
关键词
antitumor effect; combinational therapy; multimodal therapy; platinum drugs; platinum-resistance; SQUAMOUS-CELL CARCINOMA; HEPATOCELLULAR-CARCINOMA; CANCER RECURRENCE; DRUG-DELIVERY; CISPLATIN RESISTANCE; PHOTODYNAMIC THERAPY; RATIONAL DESIGN; NANOFIBER MATS; PT(IV) PRODRUG; TUMOR-CELLS;
D O I
10.1002/adhm.202300253
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Platinum drugs with manifest therapeutic effects are widely used, but their systemic toxicity and the drug resistance acquired by cancer cells limit their clinical applications. Thus, the exploration on appropriate methods and strategies to overcome the limitations of traditional platinum drugs becomes extremely necessary. Combination therapy of platinum drugs can inhibit tumor growth and metastasis in an additive or synergistic manner, and can potentially reduce the systemic toxicity of platinum drugs and overcome platinum-resistance. This review summarizes the various modalities and current progress in platinum-based combination therapy. The synthetic strategies and therapeutic effects of some platinum-based anticancer complexes in the combination of platinum drugs with gene editing, ROS-based therapy, thermal therapy, immunotherapy, biological modelling, photoactivation, supramolecular self-assembly and imaging modality are briefly described. Their potential challenges and prospects are also discussed. It is hoped that this review will inspire researchers to have more ideas for the future development of highly effective platinum-based anti-cancer complexes.
引用
收藏
页数:18
相关论文
共 50 条
  • [31] Fighting the resistance: rejuvenating anticancer platinum-based drugs
    O'Hare, Alice
    NANOMEDICINE, 2012, 7 (07) : 947 - 948
  • [32] Revisiting Platinum-Based Anticancer Drugs to Overcome Gliomas
    Jeon, Jaewan
    Lee, Sungmin
    Kim, Hyunwoo
    Kang, Hyunkoo
    Youn, HyeSook
    Jo, Sunmi
    Youn, BuHyun
    Kim, Hae Yu
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (10)
  • [33] Fighting the resistance: rejuvenating anticancer platinum-based drugs
    O'Hare, Alice
    FUTURE MEDICINAL CHEMISTRY, 2012, 4 (11) : 1380 - 1380
  • [34] Copy number footprints of platinum-based anticancer therapies
    Gonzalez, Santiago A.
    Lopez-Bigas, Nuria J.
    Gonzalez-Perez, Abel A.
    PLOS GENETICS, 2023, 19 (02):
  • [35] Polymeric Drug Delivery of Platinum-Based Anticancer Agents
    Haxton, Katherine J.
    Burt, Helen M.
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2009, 98 (07) : 2299 - 2316
  • [36] Nanoprecipitation of metallocages for platinum-based anticancer drug delivery
    Zheng, Yaorong
    Yue, Zhizhou
    Wang, Han
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2017, 254
  • [37] Polymeric biomaterials for the delivery of platinum-based anticancer drugs
    Kim, Jihoon
    Pramanick, Swapan
    Lee, Duhwan
    Park, Hansoo
    Kim, Won Jong
    BIOMATERIALS SCIENCE, 2015, 3 (07) : 1002 - 1017
  • [38] The rediscovery of platinum-based cancer therapy
    Rottenberg, Sven
    Disler, Carmen
    Perego, Paola
    NATURE REVIEWS CANCER, 2021, 21 (01) : 37 - 50
  • [39] The rediscovery of platinum-based cancer therapy
    Sven Rottenberg
    Carmen Disler
    Paola Perego
    Nature Reviews Cancer, 2021, 21 : 37 - 50
  • [40] Update Advances in Investigation of Coordinating Interactions between Platinum-Based Anticancer Drugs and Proteins by Mass Spectrometry
    Huang C.
    Liang Z.-J.
    Zhao Y.
    Fang T.-T.
    Wu K.
    Luo Q.
    Wang F.-Y.
    Journal of Chinese Mass Spectrometry Society, 2021, 42 (05): : 819 - 844